Excessive Daytime Sleepiness EDS Diagnosis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Excessive Daytime Sleepiness (EDS) Diagnosis Market is segemented By Drug Type (Stimulants, Orexin R...

Excessive Daytime Sleepiness EDS Diagnosis Market Size

Market Size in USD Bn

CAGR9.4%

Study Period2025-2032
Base Year of Estimation2024
CAGR9.4%
Market ConcentrationMedium
Major PlayersJazz Pharmaceuticals, Takeda Pharmaceutical Company, Harmony Biosciences, Avadel Pharmaceuticals, Bioprojet Pharma and Among Others
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

Excessive Daytime Sleepiness EDS Diagnosis Market Analysis

The excessive daytime sleepiness (EDS) diagnosis market is estimated to be valued at USD 7.44 billion in 2025 and is expected to reach USD 13.95 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2032.

The excessive daytime sleepiness (EDS) diagnosis market is growing at a steady rate due to the increasing awareness about sleep disorders and their diagnosis. Rise in lifestyle diseases globally is also leading to increased chances of developing sleep problems.